These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36050648)

  • 1. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out.
    Joseph Davey D; Hsiao NY; Wendy Spearman C; Sonderup M; Hu NC; Mashele N; Mvududu R; Myer L
    BMC Infect Dis; 2022 Sep; 22(1):719. PubMed ID: 36050648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
    Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
    Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial.
    Moodley D; Lombard C; Govender V; Naidoo M; Desmond AC; Naidoo K; Mhlongo O; Sebitloane M; Newell ML; Clark R; Rooney JF; Gray G;
    Lancet HIV; 2023 Mar; 10(3):e154-e163. PubMed ID: 36746169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
    Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
    BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa.
    Chotun N; Nel E; Cotton MF; Preiser W; Andersson MI
    Vaccine; 2015 Aug; 33(36):4618-22. PubMed ID: 26163924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with hepatitis B susceptibility among men who sex with men on HIV pre-exposure prophylaxis in Northeastern Brazil: a cross-sectional study.
    Vechi HT; de Freitas CHS; de Lira Nunes Paulino F; de Moura MGM; de Sant'anna JGFC; Bay MB; de Lima KC
    BMC Infect Dis; 2024 Aug; 24(1):795. PubMed ID: 39118019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
    Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
    Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    Solomon MM; Schechter M; Liu AY; McMahan VM; Guanira JV; Hance RJ; Chariyalertsak S; Mayer KH; Grant RM;
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):281-6. PubMed ID: 26413853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa.
    Andersson MI; Maponga TG; Ijaz S; Barnes J; Theron GB; Meredith SA; Preiser W; Tedder RS
    Vaccine; 2013 Nov; 31(47):5579-84. PubMed ID: 23973500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
    Ekouevi DK; Larrouy L; Gbeasor-Komlanvi FA; Mackiewicz V; Tchankoni MK; Bitty-Anderson AM; Gnatou GY; Sadio A; Salou M; Dagnra CA; Descamps D; Coffie PA
    BMC Infect Dis; 2020 Nov; 20(1):839. PubMed ID: 33183254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-prevalence of human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis.
    Kafeero HM; Ndagire D; Ocama P; Walusansa A; Sendagire H
    Virol J; 2020 Nov; 17(1):170. PubMed ID: 33160386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?
    Mohareb AM; Kouamé MG; Nouaman M; Kim AY; Larmarange J; Neilan AM; Lacombe K; Freedberg KA; Boyd A; Coffie P; Hyle EP
    J Int AIDS Soc; 2024 Mar; 27(3):e26218. PubMed ID: 38444112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional study.
    Manyahi J; Msigwa Y; Mhimbira F; Majigo M
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):109. PubMed ID: 28388879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting.
    Thumbiran NV; Moodley D; Parboosing R; Moodley P
    S Afr Med J; 2014 Apr; 104(4):307-9. PubMed ID: 25118561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-Care Sexually Transmitted Infection Testing Improves HIV Preexposure Prophylaxis Initiation in Pregnant Women in Antenatal Care in Cape Town, South Africa, 2019 to 2021.
    de Voux A; Mvududu R; Happel A; Jaspan HB; Nyemba DC; Mashele N; Myer L; Davey DLJ
    Sex Transm Dis; 2023 Feb; 50(2):92-97. PubMed ID: 36630416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
    Mugo NR; Hong T; Celum C; Donnell D; Bukusi EA; John-Stewart G; Wangisi J; Were E; Heffron R; Matthews LT; Morrison S; Ngure K; Baeten JM;
    JAMA; 2014 Jul 23-30; 312(4):362-71. PubMed ID: 25038355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.